Morgan Stanley Neuroone Medical Technologies Corp Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Morgan Stanley holds 13,436 shares of NMTC stock, worth $11,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,436
Previous 11,946
12.47%
Holding current value
$11,017
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NMTC
# of Institutions
34Shares Held
13.6MCall Options Held
125KPut Options Held
0-
Bleichroeder LP New York, NY4MShares$3.28 Million0.86% of portfolio
-
Sio Capital Management, LLC New York, NY3.52MShares$2.89 Million1.14% of portfolio
-
Bard Associates Inc Chicago, IL1.85MShares$1.52 Million0.47% of portfolio
-
Perkins Capital Management Inc1.5MShares$1.23 Million1.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.2MShares$986,1300.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $13.3M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...